Cite
Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis.
MLA
Yang, Xiangbo, et al. “Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis.” Angewandte Chemie, vol. 134, no. 5, Jan. 2022, pp. 1–5. EBSCOhost, https://doi.org/10.1002/ange.202114922.
APA
Yang, X., Lu, H., Xie, H., Zhang, B., Nie, T., Fan, C., Yang, T., Xu, Y., Su, H., Tang, W., & Zhou, B. (2022). Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis. Angewandte Chemie, 134(5), 1–5. https://doi.org/10.1002/ange.202114922
Chicago
Yang, Xiangbo, Huimin Lu, Hang Xie, Binbin Zhang, Tianqing Nie, Chen Fan, Tao Yang, et al. 2022. “Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis.” Angewandte Chemie 134 (5): 1–5. doi:10.1002/ange.202114922.